Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...

A study led by the University of Texas Health Science Center at San Antonio found women had a 31% greater risk of developing ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

New findings add weight to the theory that COVID-19 originated at the Wuhan Institute of Virology. Experts point to lax ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

Half a decade since coronavirus SARS-CoV-2 plunged the world into a pandemic, the scars are still healing for those who lost ...

As we reflect on five years since the tumultuous start of the COVID pandemic (even if we just wish to forget it ever happened ...

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an important connection for rheumatologists as they sort through symptoms and ...

Bispecific antibodies targeting multiple SARS-CoV-2 sites offer enhanced neutralization against emerging variants, advancing ...